SCHEMBL9017200

SCHEMBL9017200

COc1ccc(F)cc1N1CCN(CC(O)CNc2nccc(C(N)=O)n2)CC1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 4/20 0.59
ADRA1A P35348 4/20 0.59
ADRA1B P35368 3/20 0.59
DRD3 P35462 9/20 0.48
DRD2 P14416 6/20 0.48
DRD4 P21917 3/20 0.47
DRD1 P21728 1/20 0.47
RECQL P46063 1/20 0.46
ADRB2 P07550 2/20 0.44
ADRB1 P08588 2/20 0.44
ADRB3 P13945 2/20 0.44
HTR1A P08908 3/20 0.42
HTR2A P28223 2/20 0.42
HTR2C P28335 2/20 0.42
CCNT1 O60563 1/20 0.42
CDK9 P50750 1/20 0.42
HTR7 P34969 1/20 0.42
SLC6A4 P31645 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL9585852 0.95 ADRA1D (0.54) ADRA1DADRA1AADRA1BDRD3DRD2
Fumaric Acid SCHEMBL9585847 0.95 ADRA1D (0.54) ADRA1DADRA1AADRA1BDRD3DRD2
SCHEMBL9017186 0.90 ADRA1D (0.73) ADRA1DADRA1AADRA1BDRD3DRD2
Hydrochloric Acid SCHEMBL9586428 0.89 ADRA1D (0.72) ADRA1DADRA1AADRA1BDRD3DRD2
SCHEMBL9199195 0.84 ADRA1D (0.81) ADRA1DADRA1AADRA1BDRD3DRD2
SCHEMBL9192958 0.84 ADRA1A (0.69) ADRA1DADRA1AADRA1BDRD3DRD2
SCHEMBL9195086 0.83 ADRA1D (0.63) ADRA1DADRA1AADRA1BDRD3DRD2
SCHEMBL9570990 0.81 ADRA1D (0.72) ADRA1DADRA1AADRA1BADRB2ADRB1
SCHEMBL9199034 0.80 ADRA1A (0.62) ADRA1DADRA1AADRA1BDRD3DRD2
SCHEMBL9585946 0.79 ADRA1D (0.58) ADRA1DADRA1AADRA1BRECQLHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0522915-B1 Pyrimidine-4-carboxamide derivatives, their preparation and their use in therapeutics SYNTHELABO (FR) 1996-03-13 EP disclosed
US-5244901-A Multistage preparation by starting with a phenylpiperazine and an epoxide or chloro alcohol containing a phthalimido group; use to treat disorders involving hyperactivity of the alpha 1-adrenergic system SYNTHELABO (FR) 1993-09-14 US disclosed
EP-0522915-A1 Pyrimidine-4-carboxamide derivatives, their preparation and their use in therapeutics SYNTHELABO (FR) 1993-01-13 EP disclosed